Additive effect of sirolimus and hydroxycarbamide on fetal haemoglobin level in kidney transplant patients with sickle cell disease

Br J Haematol. 2019 Jun;185(5):959-961. doi: 10.1111/bjh.15665. Epub 2018 Nov 8.

Authors

Adil A Al-Khatti¹, Ahmed M Alkhunaizi²

Affiliations

¹ Haematology-oncology unit, Cancer Institute, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
² Nephrology unit, Specialty Internal Medicine Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

PMID: 30407620
DOI: 10.1111/bjh.15665

No abstract available

Keywords: fetal haemoglobin; hydroxycarbamide; sickle cell disease; sirolimus.

Publication types

Case Reports
Letter

MeSH terms

Adult
Anemia, Sickle Cell / drug therapy*
Anemia, Sickle Cell / pathology
Anemia, Sickle Cell / therapy*
Female
Fetal Hemoglobin / drug effects*
Humans
Hydroxyurea / pharmacology
Hydroxyurea / therapeutic use*
Kidney Transplantation / methods*
Male
Middle Aged
Sirolimus / pharmacology
Sirolimus / therapeutic use*

Substances

Fetal Hemoglobin
Sirolimus
Hydroxyurea